Last checked at 
(Sharecast News) - Brain health company Cambridge Cognition has won a £2m contract as the cognitive assessment partner for three late-phase clinical trials for a pharmaceutical company's lead drug candidate for patients with schizophrenia, it announced on Tuesday.
The AIM-traded firm said it was one of the largest single contracts it had secured, with the revenue expected to be booked over the next four years, and the majority recognised in 2021.
It explained that schizophrenia is a psychotic disorder that affects more than 20 million people worldwide.
With new avenues of research being explored in recent years, more drugs had been launched, and there was increasing interest in drug development in the field.
Cognitive impairment is a core feature of schizophrenia, it said, with deficits frequently observed in memory, attention and executive functions.
Given the importance of the disorder, schizophrenia has been a core area of clinical focus for the company for the last three years as 'CANTAB' cognitive assessments had a high degree of sensitivity in measuring those distinct processes, Cambridge Cognition said.
The pharmaceutical company would conduct two five-week inpatient trials of efficacy and safety of the drug, as well as a 52-week open-label extension study.
Cambridge Cognition said it would support all three trials with its computerised cognitive assessment software, 'CANTAB', together with associated clinical trial services.
"We are delighted to have won this contract, which is considerably larger than our typical contract size, to support this large trial and work with a company that recognises the importance of sensitive and accurate cognitive assessment in schizophrenia," said chief executive officer Matthew Stork.
"It is an outstanding endorsement for CANTAB in this growing area of research."
At 1603 BST, shares in Cambridge Cognition Holdings were up 13.92% at 45p.
13 Sep 2022 15:59
UK earnings, trading statements calendar - next 7 days
| Wednesday 14 September | |
| Advanced Medical Solutions Group PLC | Half Year Results |
| Anpario PLC | Half Year Results |
| Artisanal Spirits Co PLC | Half Year Results |
| BioPharma Credit PLC | Half Year Results |
| Blackbird PLC | Half Year Results |
| Central Asia Metals PLC | Half Year Results |
| Diurnal Group PLC | Half Year Results |
| Dunelm Group PLC | Full Year Results |
| Epwin Group PLC | Half Year Results |
| Glenveagh Properties PLC | Half Year Results |
| ITM Power PLC | Full Year Results |
| Niox Group PLC | Half Year Results |
| Pan African Resources PLC | Full Year Results |
| Pharos Energy PLC | Half Year Results |
| Redrow PLC | Full Year Results |
| Ricardo PLC | Full Year Results |
| STM Group PLC | Half Year Results |
| Tullow Oil PLC | Half Year Results |
| Thursday 15 September | |
| Big Technologies PLC | Half Year Results |
| Brooks Macdonald Group PLC | Full Year Results |
| Checkit PLC | Half Year Results |
| DFS Furniture PLC | Full Year Results |
| Downing Renewables & Infrastructure Trust PLC | Half Year Results |
| Foresight Solar Fund Ltd | Half Year Results |
| Gresham House PLC | Half Year Results |
| Hilton Food Group PLC | Half Year Results |
| IG Group Holding PLC | Q1 Results |
| IGas Energy PLC | Half Year Results |
| Keystone Law Group PLC | Half Year Results |
| Kier Group PLC | Full Year Results |
| MJ Gleeson PLC | Full Year Results |
| Oxford BioMedica PLC | Half Year Results |
| Portmeirion Group PLC | Half Year Results |
| Regional REIT Ltd | Half Year Results |
| Renishaw PLC | Full Year Results |
| RTW Venture Fund Ltd | Half Year Results |
| THG PLC | Half Year Results |
| Trainline PLC | Trading Statement |
| Wickes Group PLC | Half Year Results |
| Friday 16 September | |
| Dunedin Enterprise Investment Trust PLC | Half Year Results |
| Monday 19 September | |
| City of London Investment Group PLC | Full Year Results |
| Craneware PLC | Full Year Results |
| Haleon PLC | Half Year Results |
| IQGeo Group PLC | Half Year Results |
| Tuesday 20 September | |
| Alliance Pharma PLC | Half Year Results |
| ASA International Group PLC | Half Year Results |
| Belluscura PLC | Half Year Results |
| Brown Advisory US Smaller Cos PLC | Full Year Results |
| Cambridge Cognition Holdings PLC | Half Year Results |
| EKF Diagnostics Holdings PLC | Half Year Results |
| Elixirr International PLC | Half Year Results |
| Feedback PLC | Full Year Results |
| Fintel PLC | Half Year Results |
| First Tin PLC | Half Year Results |
| Frasers Group PLC | Full Year Results |
| Gaming Realms PLC | Half Year Results |
| Good Energy Group PLC | Half Year Results |
| Henry Boot PLC | Half Year Results |
| HydrogenOne Capital Growth PLC | Half Year Results |
| Jadestone Energy PLC | Half Year Results |
| Kingfisher PLC | Half Year Results |
| Litigation Capital Management Ltd | Full Year Results |
| Moonpig PLC | Trading Statement |
| Northcoders Group PLC | Half Year Results |
| Spectral MD Holdings Ltd | Half Year Results |
| SThree PLC | Trading Statement |
| Unbound Group PLC | Half Year Results |
| Xaar PLC | Half Year Results |
| Copyright 2022 Alliance News Limited. All Rights Reserved. | |